Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
Ambey Laboratories Ltd operates in the agrochemical sector, manufacturing products for crop protection, primarily 2,4-D base chemicals, which are crucial for sustainable farming.
The company maintains high environmental, health, and safety standards and has achieved ISO 9001:2015 certification, indicating a commitment to quality and compliance.
Currently, Ambey Laboratories is planning an Initial Public Offering (IPO) to raise capital through the fresh issuance of shares alongside an offer for sale, aiming to grow its operational capabilities.
The company has established partnerships with major corporates, indicating a strong position in the agrochemical supply chain within the region.
Ambey Laboratories emphasizes sustainable manufacturing practices, which align with growing environmental awareness trends and regulatory requirements in the agricultural sector.
Industrial Products
Other Industrial Products
60 Cr
Moderate Risk
10.9
36.4
1.1
0.6
48.30
16.20
Sales CAGR
Profit CAGR
ROE
ROCE
Dhansa Labs Ltd (DHANSA) is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Ambey Laboratories Ltd operates in the agrochemical sector, manufacturing products for crop protection, primarily 2,4-D base chemicals, which are crucial for sustainable farming. The company maintains high environmental, health, and safety standards and has achieved ISO 9001:2015 certification, indicating a commitment to quality and compliance. Currently, Ambey Laboratories is planning an Initial Public Offering (IPO) to raise capital through the fresh issuance of shares alongside an offer for sale, aiming to grow its operational capabilities. The company has established partnerships with major corporates, indicating a strong position in the agrochemical supply chain within the region. Ambey Laboratories emphasizes sustainable manufacturing practices, which align with growing environmental awareness trends and regulatory requirements in the agricultural sector.
Over the past 52 weeks, Dhansa Labs Ltd has traded between a low of ₹16.20 and a high of ₹48.30. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Dhansa Labs Ltd has a market capitalization of approximately 59.87. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Dhansa Labs Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 10.85 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 59.87 Cr, Dhansa Labs Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Dhansa Labs Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Dhansa Labs Ltd is 10.85. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
0
Neutral
14
Bullish
0
Bearish
0
Neutral
46
Bullish
0
Bearish
0
Neutral
32
Bullish
0
Investor presentation
Dhansa Labs filed an investor presentation on audited FY2026 results: Revenue ₹14,153.72 lakhs (+7.82% YoY), EBITDA ₹1,221.80 lakhs (+6.31%), PAT ₹552.26 lakhs (+15.47%); announced Atrazine capacity expansion (potential +₹120–140 Cr pa) and renewable energy projects.
Earnings Conference Call
Dhansa Labs will hold its Q4 FY2026 earnings conference call on June 5, 2026 at 5:00 PM IST; dial-in numbers, registration link, participant PIN and management contact (Mr. Arcchit Gupta) provided for Q&A.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
67.00 | 73 Cr | 6.50 | 1.05 | 0.00 | 16.19 | 15.90 | 6.52 | ||
60.00 | 65 Cr | -5.26 | 28.39 | 0.00 | -46.07 | -0.47 | -18.13 | ||
53.95 | 61 Cr | 12.24 | 1.42 | 1.39 | 8.55 | 11.61 | 10.55 | ||
25.00 | 60 Cr | 10.85 | 0.61 | 0.00 | 5.59 | 7.23 | 3.66 | ||
51.00 | 56 Cr | 7.98 | 1.25 | 0.00 | 15.67 | 13.86 | 7.34 | ||
23.00 | 52 Cr | 6.41 | 0.54 | 0.00 | 8.37 | 6.78 | 2.99 | ||
597.90 | 45 Cr | 13.90 | 1.56 | 0.00 | 11.26 | 12.53 | 7.73 | ||
| Median: 7 Co. | — | 53.95 | 60 Cr | 7.98 | 1.25 | 0.00 | 8.55 | 11.61 | 6.52 |
